108541-25-9 Usage
Uses
Used in Pharmaceutical Research and Development:
1-(4-METHOXYPHENYL)-2-OXOPYRROLIDINE-3-CARBOXYLIC ACID is used as a compound in pharmaceutical research and development for its potential biological activities and therapeutic properties. Its chemical structure makes it an attractive candidate for the development of new drugs targeting various medical conditions.
Used in Anti-Inflammatory and Analgesic Activity Studies:
In the pharmaceutical industry, 1-(4-METHOXYPHENYL)-2-OXOPYRROLIDINE-3-CARBOXYLIC ACID is used as a study subject for its pharmacological effects, particularly in the areas of anti-inflammatory and analgesic activity. This application aims to explore its potential in developing new treatments for pain and inflammation-related conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 108541-25-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,8,5,4 and 1 respectively; the second part has 2 digits, 2 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 108541-25:
(8*1)+(7*0)+(6*8)+(5*5)+(4*4)+(3*1)+(2*2)+(1*5)=109
109 % 10 = 9
So 108541-25-9 is a valid CAS Registry Number.
108541-25-9Relevant academic research and scientific papers
INDOLE AMIDE DERIVATIVES AND RELATED COMPOUNDS FOR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES
-
Page/Page column 165, (2010/12/29)
This invention provides novel compounds and the novel compounds for use as a medicine, more in particular for the prevention or treatment of neurodegenerative disorders, more specifically certain neurological disorders, such as disorders collectively known as tauopathies, and disorders characterised by cytotoxic α-synuclein amyloidogenesis. The present invention also relates to the use of said novel compounds for the manufacture of medicaments useful for treating such neurodegenerative disorders. The present invention further relates to pharmaceutical compositions including said novel compounds and to methods for the preparation of said novel compounds.
